பில் ப்ரெஉஸ்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பில் ப்ரெஉஸ்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பில் ப்ரெஉஸ்ஸ் Today - Breaking & Trending Today

Avinger, Inc.: Avinger Initiates Full Commercial Launch of Tigereye Image-Guided CTO Crossing Catheter


Avinger, Inc.: Avinger Initiates Full Commercial Launch of Tigereye Image-Guided CTO Crossing Catheter
REDWOOD CITY, CA / ACCESSWIRE / January 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced full commercial launch of its Tigereye image-guided chronic total occlusion (CTO) crossing system. With the initiation of full commercial launch, current and prospective accounts throughout the US and Germany are now able to order the Tigereye device.
During the fourth quarter of 2020, Avinger conducted a limited launch at 12 clinical centers in the U.S. and Germany. Approximately 50 CTO cases were successfully performed, showcasing Tigereye s advanced clinical capabilities and excellent product reliability in a variety of lesion types and settings. ....

Redwood City , United States , Jaafer Golzar , Matt Kreps , Phil Preuss , Jeff Soinski , Mark Weinswig , Avinger Inc , Exchange Commission On , Securities Exchange , Darrow Associates Investor Relations , Peripheral Artery Disease , Chief Medical , Pantheris Next Generation , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Exchange Commission , Quarterly Reports , Relations Contact , Tiger Eye , ரெட்வுட் நகரம் , ஒன்றுபட்டது மாநிலங்களில் , மேட் க்ரெபச் , பில் ப்ரெஉஸ்ஸ் ,

Avinger Initiates Full Commercial Launch of Tigereye(TM) Image-Guided CTO Crossing Catheter


Press release content from Accesswire. The AP news staff was not involved in its creation.
Avinger Initiates Full Commercial Launch of Tigereye(TM) Image-Guided CTO Crossing Catheter
January 15, 2021 GMT
REDWOOD CITY, CA / ACCESSWIRE / January 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced full commercial launch of its Tigereye™ image-guided chronic total occlusion (CTO) crossing system. With the initiation of full commercial launch, current and prospective accounts throughout the US and Germany are now able to order the Tigereye device. ....

Redwood City , United States , Jaafer Golzar , Matt Kreps , Phil Preuss , Jeff Soinski , Mark Weinswig , Avinger Inc , Exchange Commission On , Securities Exchange , Darrow Associates Investor Relations , Peripheral Artery Disease , Chief Medical , Pantheris Next Generation , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Exchange Commission , Quarterly Reports , Relations Contact , Cardiovascular Disease , Corporate News , Diseases And Conditions , Products And Services , Health Care Industry ,